KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Cash (2016 - 2025)

Historic Change in Cash for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $131.9 million.

  • Exact Sciences' Change in Cash rose 12495.82% to $131.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.4 million, marking a year-over-year increase of 8041818.18%. This contributed to the annual value of -$3.0 million for FY2024, which is 10082.83% down from last year.
  • Per Exact Sciences' latest filing, its Change in Cash stood at $131.9 million for Q3 2025, which was up 12495.82% from $310.0 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Change in Cash registered a high of $310.0 million during Q2 2025, and its lowest value of -$740.1 million during Q2 2021.
  • Its 5-year average for Change in Cash is -$37.0 million, with a median of $14.8 million in 2023.
  • In the last 5 years, Exact Sciences' Change in Cash crashed by 2585114.82% in 2021 and then skyrocketed by 70147.68% in 2024.
  • Exact Sciences' Change in Cash (Quarter) stood at $41.7 million in 2021, then plummeted by 82.76% to $7.2 million in 2022, then surged by 105.45% to $14.8 million in 2023, then dropped by 18.94% to $12.0 million in 2024, then soared by 1002.33% to $131.9 million in 2025.
  • Its Change in Cash was $131.9 million in Q3 2025, compared to $310.0 million in Q2 2025 and -$259.5 million in Q1 2025.